Sign Out
Levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy.
Levetiracetam is indicated as adjunctive therapy in the treatment of: partial onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy; myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy; primary generalized tonic-clonic seizures in adults, adolescents and children from 6 years of age with idiopathic generalised epilepsy.
